Saturday, November 19 | 7 a.m. – 5:00 p.m. (8 Credits)

Sunday, November 20 | 7 a.m. – 11:45 a.m. (4 Credits)

Prescribing and Pharmacology of Controlled Drugs: Current Issues and Strategies for Successful Patient Care

Presented by the Medical Association of the State of Alabama and the Alabama Board of Medical Examiners

Who Should Attend

The course in Prescribing and Pharmacology of Controlled Drugs is designed for physicians in all specialties, as well as physician assistants, certified registered nurse practitioners and nurse midwives, who need or wish to increase their knowledge and ability to effectively prescribe controlled medications that have the potential for misuse and abuse.

Statement of Need
Controlled drugs are being prescribed and dispensed at an increased rate to help patients cope with pain, anxiety, depression, insomnia, ADHD and myriad other disorders. Prescribing providers of controlled substances are faced with challenges in diagnosis and patient management across a spectrum of diverse patients and clinical settings. Controlled medications are unique in that they are frequently abused directly or through diversion. It is critical that prescribers be familiar with current practice guidelines and recommendations in order to stay up to date with best practices across an array of clinical scenarios. It is also important for the prescriber to continually improve their skills in caring for patients in practice settings that may not completely align with established guidelines, thereby calling for insight and professional judgment on how best to proceed. This activity will review cutting edge, best practice recommendations and guidelines across a variety of diagnostic and clinical settings that challenge the prescribing provider. These include clinical areas such as treatment of acute and chronic pain, identification and treatment of substance use disorders (especially prescription drug abusers), and addressing unique populations such as hospice patients.

Participant Learning Objectives
After attending this course, participants will be able to:
Describe the pharmacologic profiles of benzodiazepines, and the concurrent use of stimulants.
Identify the diagnostic criteria for acute and chronic pain, anxiety disorder, insomnia, depression and substance abuse.
Employ interviewing techniques relating to the diagnosis and management of substance abuse in general and prescription drug abusers in particular.
Discuss case management strategies in special situations, such as the elderly, hospice patients and renal sufficiency.
Discuss beliefs, attitudes and stereotypes about controlled substance prescribing, controlled drug abusers and chemical dependency and consider the therapeutic implications of treatments based upon these beliefs.
Describe circumstances in which it is appropriate to refer a patient to a pain specialist.
Recognize the need for early identification and the appropriate management for persons with psychiatric problems.
Identify appropriate screening tools for healthcare providers and their teams to detect substance use disorders in private practice. 
Recognize the non-opioid approach to pharmacological treatment of post-operative pain.
Describe the best practices for Medication-Assisted treatment with Buprenorphine for the treatment of addiction involving opioid use.
Recognize that improving the way opioids are prescribed by healthcare providers can ensure patients have access to safer, more effective chronic pain treatment while reducing the number of people who misuse, or abuse these drugs.
Define the eligibility requirements, rules, protocols, applications, and renewal processes required for PAs, CRNPs, and CNMs in a collaborative practice.
Recognize the symptoms of illicit drug use in patients in the emergency room and in private practice.
Identify and construct an opioid treatment plan that will reduce the chances of prescription drug abuse and non-compliance. 

$275 Prescribing of Controlled Drugs (8 hours) – Saturday, November 19
$125 Pharmacology of Controlled Drugs (4 hours) – Sunday, November 20

AGENDA    (Click) 

Credit and Designation Statements
The Medical Foundation of Alabama designates this live activity for a maximum of 12 AMA PRA Category 1 Credits ™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Medical Association of the State of Alabama through the joint providership of the Medical Foundation of Alabama and the Medical Association of the State of Alabama.  The Medical Foundation of Alabama is accredited by the Medical Association of the State of Alabama to provide continuing medical education for physicians.

ABN CE Statement
The Medical Association of the State of Alabama is an ABN-recognized provider of continuing education (CE). This course awards AMA PRA Category 1 Credits™ which may be used toward fulfillment of the pharmacology CE requirement for Advanced Practice approval/renewal.  ABN Administrative Code §§ 610-X-10-.01(2), 610-X-10-.02(5), 610-X-10-.04(2)(e)
This course meets or exceeds the requirement for 6 hours of pharmacology CE required for renewal of Advanced Practice approval.
To claim credit for this course, nurses must electronically upload the CME transcript issued by the Medical Association to his/her individual CE Record on the ABN website.   ABN Administrative Code § 610-X-10-.07(1)(d)

Holders of an ACSC
: Any two hours of the 12-hour Prescribing course meets the ALBME CME rule requiring holders of an ACSC to have, every two years, 2 AMA PRA Category 1 Credits™ of prescribing controlled substances.

Holders of a QACSC:
The 12-hour Prescribing course is required for PAs, CRNPs and CNMs to obtain a QACSC.  To renew a QACSC, PAs, CRNPs and CNMs must attend four hours of the twelve-hour Prescribing course, or any other Board-approved prescribing controlled substances course, every two years, listed at